Literature DB >> 15284393

Bacteria in the gut: friends and foes and how to alter the balance.

R A Rastall1.   

Abstract

The activities of the bacteria resident in the colon of companion animals can have an impact upon the health of the host. Our understanding of this microbial ecosystem is presently increasing due to the development of DNA-based microbiological tools that allow identification and enumeration of nonculturable microorganisms. These techniques are changing our view of the bacteria that live in the gut, and they are facilitating dietary-intervention approaches to modulate the colonic ecosystem. This is generally achieved by the feeding of either live bacteria (probiotics) or nondigestible oligosaccharides (prebiotics) that selectively feed the indigenous probiotics. Feeding studies with a Lactobacillus acidophilus probiotic have shown positive effects on carriage of Clostridium spp. in canines and on recovery from Campylobacter spp. infection in felines. Immune function was improved in both species. Prebiotic feeding studies with lactosucrose and fructo-oligosaccharides in both cats and dogs have shown positive effects on the microflora balance. Recently synbiotic forms (a probiotic together with a prebiotic) targeted at canines have been developed that show promise as dietary-intervention tools.

Entities:  

Mesh:

Year:  2004        PMID: 15284393     DOI: 10.1093/jn/134.8.2022S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  32 in total

1.  High abundance of Escherichia during the establishment of fecal microbiota in Brazilian children.

Authors:  Carla R Taddei; Fernanda F Oliveira; Rubens T D Duarte; Silvia T Talarico; Elizabeth H Takagi; Isabel I Ramos Carvalho; Filumena M S Gomes; Kátia Brandt; Marina B Martinez
Journal:  Microb Ecol       Date:  2014-02-28       Impact factor: 4.552

2.  Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide.

Authors:  Randal Eckert; Jian He; Daniel K Yarbrough; Fengxia Qi; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

3.  Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp.

Authors:  Randal Eckert; Fengxia Qi; Daniel K Yarbrough; Jian He; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 4.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

5.  Protective effect of probiotics in the treatment of infantile eczema.

Authors:  Rong-Jun Lin; Li-Hua Qiu; Ren-Zheng Guan; Su-Juan Hu; Ying-Ying Liu; Guang-Jun Wang
Journal:  Exp Ther Med       Date:  2015-02-17       Impact factor: 2.447

6.  Distribution and gene mutation of enteric flora carrying β-glucuronidase among patients with colorectal cancer.

Authors:  Yu Li; Xiaome Zhang; Lu Wang; Yuqing Zhou; Jama Suleiman Hassan; Mingcheng Li
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 7.  The Infant Microbiome: Implications for Infant Health and Neurocognitive Development.

Authors:  Irene Yang; Elizabeth J Corwin; Patricia A Brennan; Sheila Jordan; Jordan R Murphy; Anne Dunlop
Journal:  Nurs Res       Date:  2016 Jan-Feb       Impact factor: 2.381

Review 8.  Gastrointestinal microflora, food components and colon cancer prevention.

Authors:  Cindy D Davis; John A Milner
Journal:  J Nutr Biochem       Date:  2009-08-27       Impact factor: 6.048

Review 9.  The role of gut microbiota in the pathogenesis of colorectal cancer.

Authors:  Qingchao Zhu; Renyuan Gao; Wen Wu; Huanlong Qin
Journal:  Tumour Biol       Date:  2013-02-10

10.  A feeding induced switch from a variable to a homogenous state of the earthworm gut microbiota within a host population.

Authors:  Knut Rudi; Kristin Odegård; Tine Therese Løkken; Robert Wilson
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.